Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The study, published in Nature Communications, shows that a specific subtype of ...

The comic, who has also been a Door Guy at the Comedy Store, was told that his rare cancer has a low survival rate, five ...

The treatment cost of some of the most aggressive forms of cancers like leukemia and lymphoma could now significantly come down in the UAE.In an effort to revolutionise cancer care across the Mena ...

Researchers identified a direct connection between cancer-related inflammation and the loss of motivation characteristic of advanced cancer. In a mouse study, they describe a brain pathway that starts ...

For the first time, scientists have built a detailed, interactive map of a human cell, revealing how thousands of proteins ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

A statement issued by the IIT-G said this hydrogel serves as a stable reservoir for anti-cancer drugs, releasing it in a controlled manner while sparing healthy cells from harm. The findings of ...

Jay North, known for playing Dennis Mitchell in “Dennis the Menace,” died at 73 on April 6 at his home in Lake Butler, ...

The technology, which in the past had been limited by size and cost, provides targeted doses of radiation to tumors, ...

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in the U.S.

Teddi Mellencamp took to her Insta Stories on Thursday morning to share an eye-popping image as she battles stage four cancer ...